2020 Speakers

Anupam Agarwal, Vice President Global Head Of Drug Safety And Pv, Zogenix

Anupam Agarwal | Vice President Global Head Of Drug Safety And Pv | Zogenix » speaking at Drug Safety EU

Omar Aimer, Pharmacovigilance Specialist, Brunel Canada

Omar Aimer | Pharmacovigilance Specialist | Brunel Canada » speaking at Drug Safety EU

Sam Ajizian, Vice President Medical Safety, Medtronic

Sam Ajizian | Vice President Medical Safety | Medtronic » speaking at Drug Safety EU

Rama Albouaini, Senior Regulatory Affairs Manager, Mena, NewBridge Pharmaceuticals

Rama Albouaini | Senior Regulatory Affairs Manager, Mena | NewBridge Pharmaceuticals » speaking at Drug Safety EU

Gabrielle Amselem, Deputy Qppv And Psmf Manager, Alexion Pharmaceuticals

Gabrielle Amselem | Deputy Qppv And Psmf Manager | Alexion Pharmaceuticals » speaking at Drug Safety EU

Julia Appelskog, Head Of Pv Strategy, Merck Group

Julia Appelskog | Head Of Pv Strategy | Merck Group » speaking at Drug Safety EU

Felix Arellano, Global Head Safety Risk Management, F.Hoffmann-La Roche

Felix Arellano | Global Head Safety Risk Management | F.Hoffmann-La Roche » speaking at Drug Safety EU

Elizabeth Baker, Pharmaceutical Policy Program Director, Physicians Committee for Responsible Medicine

Elizabeth Baker | Pharmaceutical Policy Program Director | Physicians Committee for Responsible Medicine » speaking at Drug Safety EU

Mate Balazs, Country Head – Patient Safety – Hungary National QPPV – Hungary, Novartis Pharma AG

Mate Balazs | Country Head – Patient Safety – Hungary National QPPV – Hungary | Novartis Pharma AG » speaking at Drug Safety EU

Sylvie Bartus, Safety Global Clinical Affairs Director, Edwards Life Sciences

Sylvie Bartus | Safety Global Clinical Affairs Director | Edwards Life Sciences » speaking at Drug Safety EU

Albert Bekfi, Head Of Global Pv Operations, Gedeon Richter Plc

Albert Bekfi | Head Of Global Pv Operations | Gedeon Richter Plc » speaking at Drug Safety EU

Arvind Bellur, Senior Director, Head Of Safety Data Management, Sanofi

Arvind Bellur | Senior Director, Head Of Safety Data Management | Sanofi » speaking at Drug Safety EU

Lisa Benaise, Global Risk Minimization Physician, Device Safety, Risk Management And Pharmacovigilance, Nestle Skin Health

Lisa Benaise | Global Risk Minimization Physician, Device Safety, Risk Management And Pharmacovigilance | Nestle Skin Health » speaking at Drug Safety EU

Ruma Bhagat, Senior G.C.P. Strategy Lead And Site Innovation Group Lead, Genentech

Ruma Bhagat | Senior G.C.P. Strategy Lead And Site Innovation Group Lead | Genentech » speaking at Drug Safety EU

Raj Bhogal, Director, Safety And International, Regulatory Inspections And Global Quality, Takeda

Raj Bhogal | Director, Safety And International, Regulatory Inspections And Global Quality | Takeda » speaking at Drug Safety EU

Matthias Boedding, Senior Director, Merck KGaA

Matthias Boedding | Senior Director | Merck KGaA » speaking at Drug Safety EU

Mariette Boerstoel-Streefland, Senior Vice President Of Pharmacovigilance And Drug Safety, Alexion Pharmaceuticals

Mariette Boerstoel-Streefland | Senior Vice President Of Pharmacovigilance And Drug Safety | Alexion Pharmaceuticals » speaking at Drug Safety EU

Gloria Bustos, Head Of Pharmacovigilance Emea And Apac, Baxter Corp

Gloria Bustos | Head Of Pharmacovigilance Emea And Apac | Baxter Corp » speaking at Drug Safety EU

Scott Chandler, Vice President And Global Head Licensing And Early Development (Lead) Safety, F. Hoffmann - La Roche

Scott Chandler | Vice President And Global Head Licensing And Early Development (Lead) Safety | F. Hoffmann - La Roche » speaking at Drug Safety EU

David Chonzi, Vice President, Head Of Pharmacovigilance And Epidemiology ( Pve), Allogene Therapeutics

David Chonzi | Vice President, Head Of Pharmacovigilance And Epidemiology ( Pve) | Allogene Therapeutics » speaking at Drug Safety EU

Salvatore Cicirello, Senior Director, Pharmacovigilance Innovation, Celgene

Salvatore Cicirello | Senior Director, Pharmacovigilance Innovation | Celgene » speaking at Drug Safety EU

Mircea Ciuca, Global Therapeutic Area Head Of Global Clinical Safety And Pharmacovigilance, CSL Behring

Mircea Ciuca | Global Therapeutic Area Head Of Global Clinical Safety And Pharmacovigilance | CSL Behring » speaking at Drug Safety EU

Antonia K Coppin-Renz, Director, Therapeutic Area Lead Digital Therapeutics And Deputy Eu Qppv, Otsuka Europe

Antonia K Coppin-Renz | Director, Therapeutic Area Lead Digital Therapeutics And Deputy Eu Qppv | Otsuka Europe » speaking at Drug Safety EU

Margherita D'Antuono, E.U. Q.P.P.V., Italfarmaco S.P.A.

Margherita D'Antuono | E.U. Q.P.P.V. | Italfarmaco S.P.A. » speaking at Drug Safety EU

Fabio De Gregorio, Vice President And Head Of Drug Safety, Shionogi Ltd

Fabio De Gregorio | Vice President And Head Of Drug Safety | Shionogi Ltd » speaking at Drug Safety EU

Daniel De Schryver, Global Therapeutic Area Communications Leader, Infectious Diseases And Vaccines, Janssen

Daniel De Schryver | Global Therapeutic Area Communications Leader, Infectious Diseases And Vaccines | Janssen » speaking at Drug Safety EU

Peter De Veene, Qppv, Alexion Pharmaceuticals

Peter De Veene | Qppv | Alexion Pharmaceuticals » speaking at Drug Safety EU

Jean-Christophe Delumeau, Head Of Pharmacovigilance Policy Strategy (Global), Bayer Healthcare

Jean-Christophe Delumeau | Head Of Pharmacovigilance Policy Strategy (Global) | Bayer Healthcare » speaking at Drug Safety EU

Daniela Di Cosmo, Pharmacovigilance Manager, FERRING Pharmaceuticals

Daniela Di Cosmo | Pharmacovigilance Manager | FERRING Pharmaceuticals » speaking at Drug Safety EU

Tatjana Ajhler Duretek, Head Of Medical Affairs And Pharmacovigilance, Belupo

Tatjana Ajhler Duretek | Head Of Medical Affairs And Pharmacovigilance | Belupo » speaking at Drug Safety EU

Marjan Dzeparoski, Ra And Pv, Bionika Pharmaceuticals

Marjan Dzeparoski | Ra And Pv | Bionika Pharmaceuticals » speaking at Drug Safety EU

Philip Eichorn, Senior Director, Pfizer Ltd

Philip Eichorn | Senior Director | Pfizer Ltd » speaking at Drug Safety EU

Kal Elhoregy, Director, Risk Evaluation And Mitigation Strategy (Rems) Programs - Regualtory Affairs Clinical, Amneal Pharmaceuticals

Kal Elhoregy | Director, Risk Evaluation And Mitigation Strategy (Rems) Programs - Regualtory Affairs Clinical | Amneal Pharmaceuticals » speaking at Drug Safety EU

Andrew Erdman, Vice President, Global Head Of Early Development Safety, Genentech

Andrew Erdman | Vice President, Global Head Of Early Development Safety | Genentech » speaking at Drug Safety EU

Maritess Esguerra, Principal Pharmacovigilance Process Leader, Genentech

Maritess Esguerra | Principal Pharmacovigilance Process Leader | Genentech » speaking at Drug Safety EU

Nadia Espanol, Senior Global Drug Safety Specialist, mAbxience

Nadia Espanol | Senior Global Drug Safety Specialist | mAbxience » speaking at Drug Safety EU

Giovanni Furlan, Director And Safety Risk Lead, Pfizer

Giovanni Furlan | Director And Safety Risk Lead | Pfizer » speaking at Drug Safety EU

Santiago Garnica Velandia, Drug Safety Coordinator, VITALIS SACI

Santiago Garnica Velandia | Drug Safety Coordinator | VITALIS SACI » speaking at Drug Safety EU

Stewart Geary, Senior Vice President, Chief Medical Officer, Director, Corporate Medical Affairs Headquarters, Eisai

Stewart Geary | Senior Vice President, Chief Medical Officer, Director, Corporate Medical Affairs Headquarters | Eisai » speaking at Drug Safety EU

Marie Aavang Geist, Head Of Clinical Safety, Orphazyme

Marie Aavang Geist | Head Of Clinical Safety | Orphazyme » speaking at Drug Safety EU

Vishal Ghori, Biosimilars Safety Product Lead, Fresenius Kabi SwissBiosim GmbH

Vishal Ghori | Biosimilars Safety Product Lead | Fresenius Kabi SwissBiosim GmbH » speaking at Drug Safety EU

Jorge González Borroto, Pharmacovigilance Officer And Senior Toxicologist, Ferrer Internacional, S.A.

Jorge González Borroto | Pharmacovigilance Officer And Senior Toxicologist | Ferrer Internacional, S.A. » speaking at Drug Safety EU

Belen Granell Villen, Quality And Safety Policy Executive, ABPI

Belen Granell Villen | Quality And Safety Policy Executive | ABPI » speaking at Drug Safety EU

Liana Gross Martirosyan, Alternate Prac Member, Netherlands

Liana Gross Martirosyan | Alternate Prac Member | Netherlands » speaking at Drug Safety EU

Uwe Gudat, Head Of Clinical Safety And Pharmacovigilance Clinical Safety And Pharmacovigilance, Fresenius Kabi

Uwe Gudat | Head Of Clinical Safety And Pharmacovigilance Clinical Safety And Pharmacovigilance | Fresenius Kabi » speaking at Drug Safety EU

Israel Gutierrez, Vice President Pharmacovigilance And Drug Safety, Geron Corporation

Israel Gutierrez | Vice President Pharmacovigilance And Drug Safety | Geron Corporation » speaking at Drug Safety EU

Dominique Hamerlijnck, Patient Experience Expert, Innovative Medicines Initiative

Dominique Hamerlijnck | Patient Experience Expert | Innovative Medicines Initiative » speaking at Drug Safety EU

Fabian Heisig, Head Of Safety, Benefit Risk And Global Drug Safety, Grunenthal

Fabian Heisig | Head Of Safety, Benefit Risk And Global Drug Safety | Grunenthal » speaking at Drug Safety EU

Leona Houghton, Senior Director, Global Head Pharmacovigilance Quality And Compliance, Jazz Pharmaceutical

Leona Houghton | Senior Director, Global Head Pharmacovigilance Quality And Compliance | Jazz Pharmaceutical » speaking at Drug Safety EU

Kristof Huysentruyt, Director, Head Of Safety Data Management And Technology, UCB

Kristof Huysentruyt | Director, Head Of Safety Data Management And Technology | UCB » speaking at Drug Safety EU

Avinash Kakade, Sgm, Global Head- Pharmacovigilance,, Lupin

Avinash Kakade | Sgm, Global Head- Pharmacovigilance, | Lupin » speaking at Drug Safety EU

Peter Kapitein, President And Patient Advocate, Inspire2Live

Peter Kapitein | President And Patient Advocate | Inspire2Live » speaking at Drug Safety EU

Kare Kemp, Senior Head Of Pharmacovigilance Advisor, Team Leader And Section And Safety, Laegemiddelstyrelsen

Kare Kemp | Senior Head Of Pharmacovigilance Advisor, Team Leader And Section And Safety | Laegemiddelstyrelsen » speaking at Drug Safety EU

Ranjana Khanna, Director, Head Of Pv Quality Assurance, Vifor Pharma

Ranjana Khanna | Director, Head Of Pv Quality Assurance | Vifor Pharma » speaking at Drug Safety EU

Shahram Khanzadeh, Medical Director Safety And Pharmacovigilance, Arena Pharmaceuticals

Shahram Khanzadeh | Medical Director Safety And Pharmacovigilance | Arena Pharmaceuticals » speaking at Drug Safety EU

Smruti Kothari, Associate Director, Pv Quality Operations, Alexion Pharmaceuticals

Smruti Kothari | Associate Director, Pv Quality Operations | Alexion Pharmaceuticals » speaking at Drug Safety EU

Paola Kruger, Patient Expert, Eupati

Paola Kruger | Patient Expert | Eupati » speaking at Drug Safety EU

Sergiy Kryvych, Drug Safety Officer, Pfizer

Sergiy Kryvych | Drug Safety Officer | Pfizer » speaking at Drug Safety EU

Manni Kuthiala, Pv Affiliate Strategic Alliance Manager, Roche

Manni Kuthiala | Pv Affiliate Strategic Alliance Manager | Roche » speaking at Drug Safety EU

Sally Lee, Senior Direct, Epidemiology, Global Drug Safety And Risk Management, Celgene

Sally Lee | Senior Direct, Epidemiology, Global Drug Safety And Risk Management | Celgene » speaking at Drug Safety EU

András Lehoczki, Director Global Drug Safety Head Data Operations, Grünenthal USA

András Lehoczki | Director Global Drug Safety Head Data Operations | Grünenthal USA » speaking at Drug Safety EU

Valentina Mancini, Director Pharmacovigilance And Eu Qppv, Shionogi Inc

Valentina Mancini | Director Pharmacovigilance And Eu Qppv | Shionogi Inc » speaking at Drug Safety EU

Monika Manske, Associate Director Of Global Pharmacovigilance Governance, Mylan

Monika Manske | Associate Director Of Global Pharmacovigilance Governance | Mylan » speaking at Drug Safety EU

Rie Matsui, Director, Regional Labeling Head Of Asia, Pfizer

Rie Matsui | Director, Regional Labeling Head Of Asia | Pfizer » speaking at Drug Safety EU

Andrea Maulwurf, Head Of Pharmacovigilance, Eu-Qppv, Allergy Therapeutics

Andrea Maulwurf | Head Of Pharmacovigilance, Eu-Qppv | Allergy Therapeutics » speaking at Drug Safety EU

Adrian Maynier, Project Lead, UCB

Adrian Maynier | Project Lead | UCB » speaking at Drug Safety EU

Tarik Messaoud, Drug Safety Specialist Pharmacovigilance Specialist, Merck

Tarik Messaoud | Drug Safety Specialist Pharmacovigilance Specialist | Merck » speaking at Drug Safety EU

Jeremie Dedessus Le Moutier, Head Of Pharmacovigilance Excellence And Compliance, GSK

Jeremie Dedessus Le Moutier | Head Of Pharmacovigilance Excellence And Compliance | GSK » speaking at Drug Safety EU

Sutirtha Mukhopadhyay, Global Safety Officer, Ablynx

Sutirtha Mukhopadhyay | Global Safety Officer | Ablynx » speaking at Drug Safety EU

Muhammad Ashar Naeem, Global Director Pharmacovigilance And Medical Affair, Jamjoom Pharma

Muhammad Ashar Naeem | Global Director Pharmacovigilance And Medical Affair | Jamjoom Pharma » speaking at Drug Safety EU

Andras Nagy, Rmp Manager - Deputy Country Patient Safety Head, Novartis Hungary

Andras Nagy | Rmp Manager - Deputy Country Patient Safety Head | Novartis Hungary » speaking at Drug Safety EU

Jaylaxmi Nalawade, Associate Director, Lupin Ltd

Jaylaxmi Nalawade | Associate Director | Lupin Ltd » speaking at Drug Safety EU

Yvonne Nanciu, Senior Manager - Pharmacovigilance And Medical Information, abbvie

Yvonne Nanciu | Senior Manager - Pharmacovigilance And Medical Information | abbvie » speaking at Drug Safety EU

Mary Ngome, Head Of Medical, Regulatory, Quality Affairs And Pharmacovigilance, Middle Africa, Novo nordisk

Mary Ngome | Head Of Medical, Regulatory, Quality Affairs And Pharmacovigilance, Middle Africa | Novo nordisk » speaking at Drug Safety EU

Attila Olah, Head Global Pharmacovigilance, Eu-Qppv, Gedeon Richter Plc

Attila Olah | Head Global Pharmacovigilance, Eu-Qppv | Gedeon Richter Plc » speaking at Drug Safety EU

Andrew Olaharski, Senior Director And Head Of Toxicology, K.S.Q. Therapeutics

Andrew Olaharski | Senior Director And Head Of Toxicology | K.S.Q. Therapeutics » speaking at Drug Safety EU

Andrea Oliva, Head Of Pharmacovigilance, Mylan Inc.

Andrea Oliva | Head Of Pharmacovigilance | Mylan Inc. » speaking at Drug Safety EU

Vishakha Oza, Global Safety Lead Scientist, Grünenthal GmbH

Vishakha Oza | Global Safety Lead Scientist | Grünenthal GmbH » speaking at Drug Safety EU

Raphael Pareschi, Pharmacovigilance Associate Director, Pv Country Lead Deputy, Merck

Raphael Pareschi | Pharmacovigilance Associate Director, Pv Country Lead Deputy | Merck » speaking at Drug Safety EU

Tanja Peters, Deputy Eu-Qppv, Head Pv Intelligence, Boehringer Ingelheim Pharma GmbH & Co. KG

Tanja Peters | Deputy Eu-Qppv, Head Pv Intelligence | Boehringer Ingelheim Pharma GmbH & Co. KG » speaking at Drug Safety EU

Keya Pitts, Head, Quality, Standards, And Compliance, Global Patient Safety And Risk Management, Alnylam Pharmaceuticals

Keya Pitts | Head, Quality, Standards, And Compliance, Global Patient Safety And Risk Management | Alnylam Pharmaceuticals » speaking at Drug Safety EU

Mary Lynne Van Poelgeest-Pomfret, President, President of the World Federation for Incontinence and Pelvic Pain - WFIP

Mary Lynne Van Poelgeest-Pomfret | President | President of the World Federation for Incontinence and Pelvic Pain - WFIP » speaking at Drug Safety EU

Nicolas Praet, Senior Epidemiologist Director, GlaxoSmithKline

Nicolas Praet | Senior Epidemiologist Director | GlaxoSmithKline » speaking at Drug Safety EU

Nibedita Rath, Scientific Director, Open Source Pharma Foundation

Nibedita Rath | Scientific Director | Open Source Pharma Foundation » speaking at Drug Safety EU

Jackie Roberts, Vice President Scientific Affairs, Governance, Accord Healthcare

Jackie Roberts | Vice President Scientific Affairs, Governance | Accord Healthcare » speaking at Drug Safety EU

Burkhard Roessink, Senior Medical Director, GE

Burkhard Roessink | Senior Medical Director | GE » speaking at Drug Safety EU

Rodrigo Ruiz, Head Of Country Pharmacovigilance Mexico, Bristol-Myers Squibb

Rodrigo Ruiz | Head Of Country Pharmacovigilance Mexico | Bristol-Myers Squibb » speaking at Drug Safety EU

Frederick Sannajust, Former Executive Director Of Safety & Exploratory Safety Pharmacology At Merck, Independent Consultant, Independent Consultant

Frederick Sannajust | Former Executive Director Of Safety & Exploratory Safety Pharmacology At Merck, Independent Consultant | Independent Consultant » speaking at Drug Safety EU

Marco Sardella, Chief Pharmacovigilance Officer And Q.P.P.V. For Europe, Adienne

Marco Sardella | Chief Pharmacovigilance Officer And Q.P.P.V. For Europe | Adienne » speaking at Drug Safety EU

Marcus Schartau, Safety Surveillance Risk Management Specialist, Safety Surveillance, Novo Nordisk A/S

Marcus Schartau | Safety Surveillance Risk Management Specialist, Safety Surveillance | Novo Nordisk A/S » speaking at Drug Safety EU

Rudi Scheerlinck, Global Head Pharmacovigilance Risk Management, Nestle Skin Health

Rudi Scheerlinck | Global Head Pharmacovigilance Risk Management | Nestle Skin Health » speaking at Drug Safety EU

Nicole Schellmann, Specialist Quality Management, Psmf Coordinator, Mylan Inc.

Nicole Schellmann | Specialist Quality Management, Psmf Coordinator | Mylan Inc. » speaking at Drug Safety EU

Heike Schoepper, Vice President, Head Of Business Unit For Consumer Healthcare, Sanofi

Heike Schoepper | Vice President, Head Of Business Unit For Consumer Healthcare | Sanofi » speaking at Drug Safety EU

Haris Shaikh, Senior Director Pharmacovigilance, Orchard Therapeutics

Haris Shaikh | Senior Director Pharmacovigilance | Orchard Therapeutics » speaking at Drug Safety EU

Chetan Shatapathy, Principal Pharmacovigilance Physician, AstraZeneca Ltd.

Chetan Shatapathy | Principal Pharmacovigilance Physician | AstraZeneca Ltd. » speaking at Drug Safety EU

Priya Singhal, Head Of Research And Development, Zafgen, Inc.

Priya Singhal | Head Of Research And Development | Zafgen, Inc. » speaking at Drug Safety EU

Howard Snow, Howard Snow, Head Patient Safety, Sandoz Biopharmaceuticals, Chief Medical Office And Patient Safety, Novartis International AG

Howard Snow | Howard Snow, Head Patient Safety, Sandoz Biopharmaceuticals, Chief Medical Office And Patient Safety | Novartis International AG » speaking at Drug Safety EU

John Solomon, Head Of Pharmacovigilance, Sanofi

John Solomon | Head Of Pharmacovigilance | Sanofi » speaking at Drug Safety EU

Jens-Ulrich Stegmann, Vice President, Head Clinical Safety And Pharmacovigilance Gsk Vaccines And Eu Qppv, Viiv Healthcare, G.S.K Biologicals

Jens-Ulrich Stegmann | Vice President, Head Clinical Safety And Pharmacovigilance Gsk Vaccines And Eu Qppv, Viiv Healthcare | G.S.K Biologicals » speaking at Drug Safety EU

Doris Stenver, Former Chief Medical Officer, Member Of Prac At Ema, Danish Medicines Agency

Doris Stenver | Former Chief Medical Officer, Member Of Prac At Ema | Danish Medicines Agency » speaking at Drug Safety EU

Kristina Strutt, Head Of Pharmacovigilance, General Medicines And Emerging Markets, Sanofi

Kristina Strutt | Head Of Pharmacovigilance, General Medicines And Emerging Markets | Sanofi » speaking at Drug Safety EU

Marina Suvakov, Director, Compliance And Business Management, Otsuka Europe Development and Commercialisation Ltd

Marina Suvakov | Director, Compliance And Business Management | Otsuka Europe Development and Commercialisation Ltd » speaking at Drug Safety EU

Ricarda Tiemeyer, Head Of Drug Safety, Biogen

Ricarda Tiemeyer | Head Of Drug Safety | Biogen » speaking at Drug Safety EU

Phil Tregunno, Group Manager, Vigilance, Intelligence And Research, Medicines & Healthcare Products Regulatory Agency

Phil Tregunno | Group Manager, Vigilance, Intelligence And Research | Medicines & Healthcare Products Regulatory Agency » speaking at Drug Safety EU

Jean-Pierre Valentin, Head Of Investigative Toxicology, Ucb Belgium

Jean-Pierre Valentin | Head Of Investigative Toxicology | Ucb Belgium » speaking at Drug Safety EU

Eva Van Engelen, Associate Director Pharmacovigilance And Epidemiology, Gilead Sciences

Eva Van Engelen | Associate Director Pharmacovigilance And Epidemiology | Gilead Sciences » speaking at Drug Safety EU

Bert Van Leeuwen, Deputy Qppv, Astellas Pharma Europe BV

Bert Van Leeuwen | Deputy Qppv | Astellas Pharma Europe BV » speaking at Drug Safety EU

Anne-Ruth Van Troostenburg De Bruyn, Eu Qppv & Pv Pharmacovigilance & Epidemiology, Gilead Sciences

Anne-Ruth Van Troostenburg De Bruyn | Eu Qppv & Pv Pharmacovigilance & Epidemiology | Gilead Sciences » speaking at Drug Safety EU

Ale Maria Vazquez-Gragg, Vice President Of Global Patient Safety, Argenx

Ale Maria Vazquez-Gragg | Vice President Of Global Patient Safety | Argenx » speaking at Drug Safety EU

Paul Wang, Director Of Pharmaco Vigilance Operations, Kite Pharma, a Gilead Company

Paul Wang | Director Of Pharmaco Vigilance Operations | Kite Pharma, a Gilead Company » speaking at Drug Safety EU

Hal Ward, Vice President Of Drug Safety, Kyowa Hakko Kirin Co Ltd

Hal Ward | Vice President Of Drug Safety | Kyowa Hakko Kirin Co Ltd » speaking at Drug Safety EU

Judith Weigel, Pharmacovigilance Of Interface Regulatory Affairs, Verband Forschender Arzneimittelhersteller Ev

Judith Weigel | Pharmacovigilance Of Interface Regulatory Affairs | Verband Forschender Arzneimittelhersteller Ev » speaking at Drug Safety EU

James Whitehead, Patient Safety Medical Device Lead, Astra Zeneca

James Whitehead | Patient Safety Medical Device Lead | Astra Zeneca » speaking at Drug Safety EU

Richard Wolf, Executive Director, C.S.L. Behring Gmbh

Richard Wolf | Executive Director | C.S.L. Behring Gmbh » speaking at Drug Safety EU

Songlin Xue, Executive Vice President And Global Head Of Pharmacovigilance, Astellas Pharma

Songlin Xue | Executive Vice President And Global Head Of Pharmacovigilance | Astellas Pharma » speaking at Drug Safety EU

Get Involved At World Drug Safety Congress

 

To Sponsor Or Exhibit


Edmond Rama
edmond.rama@terrapinn.com
+44 20 7092 1052

 

 

 

To Speak


Anastasia Beretsos
Anastasia.Beretsos@terrapinn.com
+44 20 7092 1070

 

 

 

To Register


Tayyab Abbasi
tayyab.abbasi@terrapinn.com
+44 20 7092 1210